Phase II Trial of Gemcitabine/Irinotecan in Refractory or Relapsed Small-Cell Lung Cancer - Concepedia

Concepedia

Publication | Closed Access

Phase II Trial of Gemcitabine/Irinotecan in Refractory or Relapsed Small-Cell Lung Cancer

28

Citations

15

References

2005

Year

Wolfgang Schuette, S. Nagel, Stefan Juergens, I Bork, Bettina Wollschlaeger, Steffen Schaedlich, Thomas Blankenburg

Clinical Lung Cancer

OncologyPhase Ii TrialMedicinePharmacotherapyAnti-cancer AgentCancer TreatmentPharmacologyRadiation OncologySmall-cell Lung CancerLung Cancer

References

	Year	Citations

Page 1